Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001144204-18-058039
Filing Date
2018-11-07
Accepted
2018-11-07 17:19:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15683
2 PART II AND III tv506394_partiiandiii.htm PART II AND III 1223502
3 EXHIBIT 11.1 tv506394_ex11-1.htm EX1A-11 CONSENT 4033
4 GRAPHIC tv506394_img01.jpg GRAPHIC 94704
5 GRAPHIC tv506394_img02.jpg GRAPHIC 80070
6 GRAPHIC tv506394_img03.jpg GRAPHIC 71181
7 GRAPHIC tv506394_img04.jpg GRAPHIC 9925
8 GRAPHIC tv506394_img06.jpg GRAPHIC 26190
9 GRAPHIC tv506394_img07.jpg GRAPHIC 7295
  Complete submission text file 0001144204-18-058039.txt   1643777
Mailing Address 733 THIRD AVENUE FLOOR 15 NEW YORK NY 10017
Business Address 733 THIRD AVENUE FLOOR 15 NEW YORK NY 10017 646-790-5756
Glucose Biosensor Systems (Greater China) Holdings, Inc. (Filer) CIK: 0001725430 (see all company filings)

EIN.: 821512711 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 1-A/A | Act: 33 | File No.: 024-10911 | Film No.: 181167410
SIC: 3841 Surgical & Medical Instruments & Apparatus